Overzicht Proefschriften
Tips in using the search/filter fieldsGo to page:
- of 6
- >
Displaying 1-50 of 278 results.
Titel | Promovendus | Promotor 1 | Promotor 2 | Copromotor 1 | Copromotor 2 | Universiteit | Promotiejaar | Trefwoorden |
---|---|---|---|---|---|---|---|---|
Strategies for optimization of aminoglycoside and vancomycin therapies | Maarseveen E.M. van, PhD | Neef C., prof. dr. | Touw D.J., prof. dr. | Zanten A.R. van, dr. | 2014 | |||
Immunological aspects of conventional and new treatments for cervical cancer, an immunopharmacological approach | Meir H. van | Burg S.H van der, Prof.dr. | Burggraaf J., prof. dr. | Kalkman C.J., prof. dr. | Peeters M.Y.M., dr. | 2017 | Immunotherapy Combined chemo-immunotherapy Cervical cancer HPV16-SLP vaccination Immunomonitoring | |
Angiotensin II-induced vasodilation: role of bradykinin, NO and endothelium-derived hyperpolarizing factors | Batenburg W.W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Cardiac aldosterone: origin and effects | Chai W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Vascular pharmacology of migraine and preeclampsia: Problems of the fair sex | Gupta S., dr. | Saxena P.R., prof. dr. | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2006 | Cardiovascular disease; Pharmacology; | |
Characterization of vascular 5-hydroxytryptamine, adrenergic and CGRP receptors in relation to migraine | Mehrotra S., dr. | Saxena P.R., prof. dr. | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2006 | Cardiovascular disease; Pharmacology; | |
Unraveling the complexities of the renin-angiotensin system: from ACE to renin inhibition | Esch J.H.M. van, dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2008 | Cardiovascular disease; Pharmacology; Renin-angiotensin system; | |||
(Pro)renin revisited: new insights from studies in mast cells | Krop M., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2009 | Cardiovascular disease; Pharmacology; Prorenin; | |||
Natriuretic peptides, diagnostics and prognostic biomarkers | Rutte J.H.W., dr. | Danser A.H.J., prof. dr. | Meiracker A.H. van den, dr. | Erasmus Universiteit Rotterdam (EUR) | 2010 | Antihypertensive drugs; Pharmacology; Kidney; Natriuretic peptides; Renine-angiotensine system; | ||
Neurovascular pharmacology of prospective antimigraine drugs | Chan K.Y., PhD | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Migraine; Neurovascular pharmacology; | ||
Aortic pathology and the role of the renin-angiotensin system | Molzer E., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Cardiovascular disease; Renin-angiotensin system; | |||
The more complex renin-angiotensin system: new insights into an old system | Gembardt F., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Renin-angiotensin system; | |||
Cardiovascular, renal and thyroid toxicity during angiogenesis inhibition: a translational approach | Kappers M.H.W., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Cancer; Pharmacology; Antihypertensive drugs; | |||
Red wine polyphenols and vascular function | Botden I.P.G., PhD | Danser A.H.J., prof. dr. | Sijbrands E.J.G., prof. dr. | Langendonk J.G., dr. | Erasmus Universiteit Rotterdam (EUR) | 2012 | Antihypertensive drugs; Cardiovascular disease; Pharmacology; | |
Vascular aging from DNA damage to protection | Ďurik M., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2012 | Cardiovascular disease; Pharmacology; | ||
The role of aldosterone and aldosterone blockade in hypertension | Jansen P.M., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2013 | Cardiovascular disease; Antihypertensive drugs; Pharmacology; | |||
Neurovascular pharmacology of migraine: epigenetics and sex hormones | Labruijere S., PhD | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Pharmacology; Migraine; Epigenetics; Neurovascular pharmacology; | ||
Novel directions in therapy against age-related vascular disease | Wu H., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Pharmacology; Cardiovascular disease; | ||
The alternative renin-angiotensin system: exploration of its therapeutic potential | Sevá Pessôa B., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Pharmacology; Cardiovascular disease; Renin-angiotensin system; | ||
The (pro)renin receptor: moving away from prorenin? | Lu X., PhD | Danser A.H.J., prof. dr. | Meima M.E., dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Cardiovascular disease; Pharmacology; Prorenin; | ||
Preeclampsia, the renin-angiotensin-aldosterone system and beyond | Verdonk K., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Pre-eclampsia; Antihypertensive drugs; Pharmacology; Primary care; Renin-angiotensin system; | |||
Drug-related problems: risk factors and the role of clinical pharmacists | Zaal R.J., PhD | Vulto A.G., prof. dr. | Haaijer-Ruskamp F.M., prof. dr. | Bemt P.M.L.A. van den, dr. | Erasmus Universiteit Rotterdam (EUR) | 2016 | Drug-related problems; Risk factors; | |
Maturation of cytochrome P450 3A mediated drug metabolism : towards individualized dosing in children | Ince I., PhD | Tibboel D., prof. dr. | Knibbe C.A.J., prof. dr. | Wildt S.N. de, prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2013 | Paediatrics; Midazolam; CYP3A; Population PK; Maturation; Metabolism; | |
Pain still hurts : pain assessment and pain management in intensive care patients | Ahlers S.J.G.M., PhD | Tibboel D., prof. dr. | Knibbe C.A.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2012 | Morphine; Remifentanil; Pain; Immune reconstitution; Intensive care; Critically ill; Analgesia; Anesthesiology; Pain assessment; Pain management; | ||
Microvasculature, the Trigeminal System and Migraine: A focus on female sex hormones | Ibrahimi K., PhD | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Meiracker A.H. van den, dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Migraine; Microvasculature; Trigeminal System; Female Sex Hormones | |
Multimodality ImAging of Cardiovascular Dysfunction: Risk factors, diagnostics and treatment options | Thiel B.S. van, PhD | Kanaar R., prof. dr. | Danser A.H.J., prof. dr. | Essers J., dr. | Pluijm I. van der, dr. | Erasmus Universiteit Rotterdam (EUR) | 2017 | Cardiovascular disease; Imaging; Aging; Risk factors; Diagnostics; Treatment options |
The Renin-Angiotensin System in Hypertension and Diabetes: From Man to Rodent and Back | Roksnoer L.C.W. | Danser A.H.J., prof. dr. | Zietse R., prof.dr. | Hoorn E.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2016 | Renin-angiotensin system; Renal function; Hypertension; Diabetic kidney disease; | |
Renin-angiotensin system and genetic factors in aneurysms: a translational approach | Riet L. te, PhD | Danser A.H.J., prof. dr. | Verhagen H.J.M., prof. dr. | Essers J., dr. | Rouwet E.V., dr. | Erasmus Universiteit Rotterdam (EUR) | 2016 | Renin-angiotensin system; Genetics; Aneurysm |
Hypertension and renal toxicity during angiogenesis inhibition: Salt dependency and treatment options | Lankhorst S. | Danser A.H.J., prof. dr. | Meiracker A.H. van den, dr. | Kappers M.H.W., PhD | Erasmus Universiteit Rotterdam (EUR) | 2016 | Hypertension; Renal function; Treatment options | |
Carotid artery contrast enhanced ultrasound | Kate G.L. ten, PhD | Sijbrands E.J.G., prof. dr. | Danser A.H.J., prof. dr. | Schinkel A.F.L., Dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Cardiovascular disease; Vascular reactivity; | |
Renin-Synthesizing Cells and Beyond | Goes Martini A., PhD | Danser A.H.J., prof. dr. | Neves F.A.R., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2017 | Renin-angiotensin system; Renal function; | ||
Multimodality ImAging of Cardiovascular Dysfunction: Risk Factors, Diagnostics and Treatment Options | Thiel B.S. van, PhD | Kanaar R., prof. dr. | Danser A.H.J., prof. dr. | Essers J., dr. | Pluijm I. van der, dr. | Erasmus Universiteit Rotterdam (EUR) | 2017 | Cardiovascular disease; Risk factors; Treatment options; |
Angiogenic imbalance in preeclampsia: pathogenic, diagnostic and prognostic implications | Saleh L., PhD | Danser A.H.J., prof. dr. | Steegers E.A.P., prof. dr. | Meiracker A.H. van den, dr. | Visser W, Dr. | Erasmus Universiteit Rotterdam (EUR) | 2018 | Pre-eclampsia; Pregnant women; Pregnancy; Renin-angiotensin system; Treatment options; |
Endothelial dysfunction in cardiovascular disease | Heuvel M. van den, PhD | Duncker D.J.G.M., Prof.dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2018 | Cardiovascular disease; Vascular reactivity; Cholesterol; | ||
DNA Damage-related Vascular Dysfunction: Pathways and Interventions | Bautista-Niño P.K., PhD | Danser A.H.J., prof. dr. | Franco Duran O.H., Prof.dr. | Roks A.J.M., dr. | Ghanbari M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2017 | Cardiovascular disease; Vascular reactivity; DNA damage; |
Sex hormones and cardiometabolic risk | Glisic M., PhD | Danser A.H.J., prof. dr. | Franco Duran O.H., Prof.dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2018 | Epidemiology; Pharmacology; Risk factors; Sex hormonesCardiovascular disease; Metabolism; | |
Vascular Effects of Current and Novel Antimigraine Drugs | Rubio Beltrán AE | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2019 | Migraine; Vascular reactivity; Drug efficacy; Pharmacology; | ||
Peripheral Projections of the Trigeminovascular System as Antimigraine Target | Labastida Ramírez A | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2019 | Migraine; Vascular reactivity; Pharmacology; | ||
New therapeutic targets in cardiovascular disease: focus on the renin-angiotensin system and lipid metabolism | Sun Y | Danser A.H.J., prof. dr. | Lu X., PhD | Erasmus Universiteit Rotterdam (EUR) | 2020 | Renin-angiotensin system; lipid metabolism; Vascular reactivity; Pharmacology; Treatment options; | ||
Towards New Therapies for Preeclampsia: Restoring Vascular Dysfunction | Hitzerd AE | Reiss IKM, prof.dr. | Danser A.H.J., prof. dr. | Simons SHP, dr. | Erasmus Universiteit Rotterdam (EUR) | 2020 | Pre-eclampsia; Treatment options; Pregnancy; Pharmacology; | |
The aging cardiovascular system: genetic and epigenetic determinants of vascular outcomes and cardiometabolic risk | Portilla Fernández E | Danser A.H.J., prof. dr. | Ikram MA, prof.dr. | Roks A.J.M., dr. | Dehghan A, dr. | Erasmus Universiteit Rotterdam (EUR) | 2019 | Cardiac aging; Cardiovascular disease; Genetics; Epidemiology; Epigenetics; Vascular reactivity; Pharmacology; |
Salt, acid, and the renin-angiotensin system in chronic kidney disease | Bovée D.M., PhD | Hoorn E.J., prof. dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2021 | Renin-angiotensin system; Kidney; Pharmacology; | ||
The role of pharmacogenetics in osteosarcoma | Hagleitner M.M., PhD | Hoogerbrugge P.M., prof. dr. | Guchelaar H.J., prof. dr. | Loo D.M.W.M. te, dr. | Coenen M.J.H., dr. | Radboud Universiteit (RU) | 2015 | Cancer; Osteosarcoma; Pharmacogenetics; Genetics; Chemotherapy; |
HIV treatment: a clinical pharmacology perspective | Luin M. van, dr. | Hekster Y.A., prof. dr. | Burger D.M., prof. dr. | Richter C., dr. | Radboud Universiteit (RU) | 2010 | Clinical pharmacology; Pharmacokinetics; HIV; Therapeutic drug monitoring; drug-drug interactions; antiretroviral drugs | |
The road to tailor made azole antifungal therapy | Brüggemann R.J.M., PhD | Burger D.M., prof. dr. | Verweij P.E., prof. dr. | Blijlevens N.M.A., dr. | Radboud Universiteit (RU) | 2011 | Antifungal; clinical pharmacology | |
Clinical pharmacology of nevirapine in HIV-infected patients in Tanzania | Muro E.P., PhD | Burger D.M., prof. dr. | Dolmans W.M.V., prof. dr. | Radboud Universiteit (RU) | 2014 | Clinical pharmacology; HIV; Pharmacokinetics; therapy drug monitoring | ||
Clinical pharmacological studies in tuberculosis patients | Semvua H.H., PhD | Burger D.M., prof. dr. | Aarnoutse R.E., dr. | Boeree M.J., dr. | Radboud Universiteit (RU) | 2014 | Clinical pharmacology; Pharmacokinetics; Tuberculosis | |
Assessment of ischaemia and reperfusion injury | Wouters C.W., PhD | Rongen G.A., prof. dr. | Oyen W.J.G., prof. dr. | Radboud Universiteit (RU) | 2013 | Ischemia/reperfusion injury; adenosine; atorvastatin; forearm; | ||
The role of efflux and influx transporters in the disposition of digitalis-like compounds | Gozalpour E., PhD | Russel F.G.M., prof. dr. | Radboud Universiteit (RU) | 2015 | ||||
The many faces of Na+, K+-ATPase: understanding the role of human isoforms in health and disease | Weigand K.M., PhD | Russel F.G.M., prof. dr. | Radboud Universiteit (RU) | 2015 |
Go to page:
- of 6
- >